No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Asset Management
The fund's core objective is to generate significant capital appreciation over the long term. It allocates a minimum of 80% of its total portfolio to equity investments, primarily common stocks, of companies engaged in the health sciences and related fields. This broad health sciences sector includes enterprises involved in healthcare equipment and supplies, healthcare providers and services, biotechnology, and pharmaceuticals. Demonstrating a focused strategy, the fund will maintain a concentrated position, investing over 25% of its assets, in these health sciences or associated industries. Additionally, it possesses the flexibility to hold shares in companies located outside the United States.
www.blackrock.com/us/individual/products/283882/health-sciences-opportunities-fundNo one on the platform currently holds SHSKX.
No tracked institution reports a position in SHSKX as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-07-22 | $6.4645 | 2026-07-23 |
| 2025-12-09 | $3.1808 | 2025-12-09 |
| 2025-07-17 | $3.8366 | 2025-07-17 |
| 2024-12-11 | $3.3850 | 2024-12-11 |
| 2024-07-18 | $2.4913 | 2024-07-18 |
| 2023-12-07 | $1.3996 | 2023-12-07 |
No one on the platform has traded SHSKX yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| SHSKXBlackRock Health Sciences Opportunities Portfolio Class K | $70.04 | -0.10% | $6.4B | — |
| FSPHXFidelity Select Health Care Portfolio | $29.29 | +0.07% | $6.8B | — |
| LMGNXClearBridge International Growth I | $72.93 | -0.37% | $7.1B | — |
| PRPFXPermanent Portfolio Permanent I | $78.17 | +0.13% | $7.4B | — |
| RBAIXT. Rowe Price Balanced I Class | $29.93 | -0.33% | $5.3B | — |
| SHISXBlackRock Health Sciences Opportunities Portfolio Service Shares | $63.94 | -0.11% | $6.4B | — |
| SHSAXBlackRock Health Sciences Opportunities Portfolio Investor A Shares | $63.51 | -0.11% | $6.4B | — |
Source: Financial Modeling Prep · peers by sector/industry
The fund's core objective is to generate significant capital appreciation over the long term. It allocates a minimum of 80% of its total portfolio to equity investments, primarily common stocks, of companies engaged in the health sciences and related fields. This broad health sciences sector includes enterprises involved in healthcare equipment and supplies, healthcare providers and services, biotechnology, and pharmaceuticals. Demonstrating a focused strategy, the fund will maintain a concentrated position, investing over 25% of its assets, in these health sciences or associated industries. Additionally, it possesses the flexibility to hold shares in companies located outside the United States.